Overall, both atheroprotective (via S100A8 expression) and proatherogenic (via SREBF1, LCAT, PRKACG, PRKACB, and PRKCQ expression) properties of HDL seem to exist in CAD patients. This evidence concerns the gene PRKCQ and coronary artery disorder.